ArticleCancer gene therapy2012

A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer.

M A Trujillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.